Exact Sciences
EXAS
#1543
Rank
S$14.88 B
Marketcap
$80.44
Share price
5.86%
Change (1 day)
-17.41%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total assets

Total assets on the balance sheet as of September 2024 : S$9.13 Billion

According to Exact Sciences's latest financial reports the company's total assets are S$9.13 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exact Sciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31S$8.54 B2.38%
2022-12-31S$8.34 B-7.63%
2021-12-31S$9.03 B38.7%
2020-12-31S$6.51 B37.86%
2019-12-31S$4.72 B127.01%
2018-12-31S$2.08 B160.07%
2017-12-31S$0.80 B46.71%
2016-12-31S$0.54 B5.97%
2015-12-31S$0.51 B24.58%
2014-12-31S$0.41 B122.5%
2013-12-31S$0.18 B35.49%
2012-12-31S$0.13 B9.2%
2011-12-31S$0.12 B0.99%
2010-12-31S$0.12 B243.64%
2009-12-31S$36.17 M328.92%
2008-12-31S$8.43 M-59.84%
2007-12-31S$21 M-42.62%
2006-12-31S$36.59 M-41.92%
2005-12-31S$63.01 M-31.16%
2004-12-31S$91.53 M55.35%
2003-12-31S$58.92 M-32.2%
2002-12-31S$86.9 M-25.6%
2001-12-31S$0.11 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
S$1.46 B-83.98%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.72 B-81.11%๐Ÿ‡บ๐Ÿ‡ธ USA
S$29.93 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
S$188.37 B 1,961.10%๐Ÿ‡ซ๐Ÿ‡ท France